Walgreens Weight Management offers virtual clinician visits for eligible adults considering FDA-approved anti-obesity medicines. Visits cost $49 each; medication is separate, and this service…
$49
8.4/10
Embody Review 2026: Pricing, Services and Safety
Embody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipping. The website discloses that compounded medicines are not FDA-approved; confirm the plan term and full upfront charge before purchase.
Quick verdict
Independent review of
Embody joinem.co
- No affiliate relationship
- Compounded medication: not FDA-approved
- Best for
- consumers who compare the selected drug, full plan length, actual charge, provider visit and cancellation/refund terms before enrolling
- Key feature
- consumer telehealth intake and clinician-review program advertising compounded GLP-1 injections
Embody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipping. The website discloses that compounded medicines are not FDA-approved; confirm the plan term and full upfront charge before purchase. Trustpilot showed a 3.8 score and more than 7,500 reviews on a profile that has been merged with other profiles. Review summaries include positive comments on easy intake and provider interactions, as well as complaints about delayed or missing shipments and difficulty getting support. These are customer reports, not verified clinical or product-quality findings.
Our rating
Pricing
Starting price
See details
- Website advertises compounded semaglutide from $79/month and compounded tirzepatide from $129/month; the checkout price depends on 4-, 12-, 24- or 52-week plan selection.
Prices can change. Check the official site for current details. Last checked September 24, 2026.
Pros and cons
Pros
- Current site posts starting prices and a disclaimer about compounded products
- Online intake and clinician review are described
- Trustpilot offers a large, though merged, public customer-feedback sample
Cons
- Displayed monthly starting price varies with treatment and plan duration
- Large profile includes merged reviews and reports of delivery/support problems
- No FDA approval for compounded medication; verify prescribing and pharmacy details
Features
Medication typeCompounded GLP-1s, which are not FDA-approved
Review summaryEmbody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipping. The website discloses that compounded medicines are not FDA-approved; confirm the plan term and full upfront charge before purchase. Trustpilot showed a 3.8 score and more than 7,500 reviews on a profile that has been merged with other profiles. Review summaries include positive comments on easy intake and provider interactions, as well as complaints about delayed or missing shipments and difficulty getting support. These are customer reports, not verified clinical or product-quality findings.
Specifications
| Service type | Online weight-loss and GLP-1 care at joinem.co |
|---|---|
| Medication type | Compounded GLP-1s, which are not FDA-approved |
| Pricing | Published charges are described in the Pricing section. Confirm the selected treatment, billing term and total at checkout. |
| Trustpilot | 3.8 / 5 from 7,507 reviews |
| Our take | Embody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipp… |
| Data status | Awaiting a verified price check |
Full review
Price not currently verified
- Our score
- 3.6/10
- Best for
- consumers who compare the selected drug, full plan length, actual charge, provider visit and cancellation/refund terms before enrolling
- Starting price
- Website advertises compounded semaglutide from $79/month and compounded tirzepatide from $129/month; the checkout price depends on 4-, 12-, 24- or 52-week plan selection.
- Trustpilot
- 3.8/5; 7507 Trustpilot reviews
Quick verdict
Embody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipping. The website discloses that compounded medicines are not FDA-approved; confirm the plan term and full upfront charge before purchase. Trustpilot showed a 3.8 score and more than 7,500 reviews on a profile that has been merged with other profiles. Review summaries include positive comments on easy intake and provider interactions, as well as complaints about delayed or missing shipments and difficulty getting support. These are customer reports, not verified clinical or product-quality findings. This is an editorial review of publicly available information; we did not purchase care or test medication. The score measures published pricing, access, service transparency, and customer feedback—not clinical effectiveness.
What the service offers
Embody’s public site promotes a short online intake, clinician review and medication if prescribed. It says it is not a pharmacy and does not control pharmacy services. The consumer should identify the treating medical group, prescriber, dispensing pharmacy and after-hours clinical contact in the order documentation.
Embody says compounded medicines have not been evaluated or approved by FDA for safety, efficacy or quality. FDA also warns that compounding is subject to patient-specific statutory conditions and that semaglutide/tirzepatide are not currently listed as shortages or on the 503B bulks list. Confirm the clinical basis for any proposed compounded prescription and discuss risks with a licensed clinician.
Pricing and what is included
Website advertises compounded semaglutide from $79/month and compounded tirzepatide from $129/month; the checkout price depends on 4-, 12-, 24- or 52-week plan selection. The table below separates advertised monthly equivalents from the terms that affect the actual amount paid. Promotion pages and plan menus can change. Check the exact prescription, supply period, full payment, renewal schedule, shipping and refund terms before checkout.
| Plan or item | Published price | Important detail |
|---|---|---|
| Compounded semaglutide | From $79/month advertised | Plan length affects price |
| Compounded tirzepatide | From $129/month advertised | Plan length affects price |
Embody advertises starting rates of $79/month for compounded semaglutide and $129/month for compounded tirzepatide. The company’s site says pricing varies by treatment and by 4-, 12-, 24- or 52-week plan shown during checkout. A monthly equivalent does not prove monthly billing. Read the exact charge, renewal, refund and cancellation terms before submitting payment.
Eligibility, clinicians and access
Confirm service availability in your state, who provides the service or makes treatment decisions, what clinical follow-up is included, and how to reach a clinician for medical questions. Benefit rules, state availability and eligibility can change. Completing an intake or payment does not guarantee that a prescription or service will be provided.
Treatment and safety considerations
Embody says compounded medicines have not been evaluated or approved by FDA for safety, efficacy or quality. FDA also warns that compounding is subject to patient-specific statutory conditions and that semaglutide/tirzepatide are not currently listed as shortages or on the 503B bulks list. Confirm the clinical basis for any proposed compounded prescription and discuss risks with a licensed clinician.
For compounded medication, FDA notes that compounding is not a substitute for FDA approval: compounded drugs are not reviewed for safety, effectiveness or quality before marketing. Federal and state rules limit when compounding is permitted. If a service offers compounded semaglutide or tirzepatide, ask the prescriber to explain the patient-specific medical need and the dispensing pharmacy. Never change a prescribed dose based on website copy or customer reviews.
Pros and cons
Pros
- Current site posts starting prices and a disclaimer about compounded products
- Online intake and clinician review are described
- Trustpilot offers a large, though merged, public customer-feedback sample
Cons
- Displayed monthly starting price varies with treatment and plan duration
- Large profile includes merged reviews and reports of delivery/support problems
- No FDA approval for compounded medication; verify prescribing and pharmacy details
Our rating
We weight price transparency at 30%, medication or product clarity at 20%, medical care and safety disclosures at 20%, access at 15%, and support and policy clarity at 15%. The weighted score is 3.6/10. It is an editorial comparison score, not a clinical rating.
| Category | Score | What we assessed |
|---|---|---|
| Cost and price transparency | 4/10 | Published prices, total charge and billing terms. |
| Medication options and sourcing | 2/10 | Treatment type, medication status and pharmacy information. |
| Medical care and safety | 4/10 | Clinician involvement and transparent safety disclosures; not treatment efficacy. |
| Ease of use and access | 5/10 | Eligibility, enrollment, geographic availability and benefit access. |
| Customer support and policies | 3/10 | Policy clarity and available broad customer feedback. |
Customer feedback
3.8out of 5 on Trustpilot7507 reviews, checked 2026-09-24
What customers praise
- Customers often discuss response times, enrollment and delivery.
What customers complain about
- Some reviewers report service or fulfillment concerns; feedback is self-reported and not clinical evidence.
Customer reviews describe individual service experiences. They are not medical evidence.
Overall company profile; Trustpilot says profiles were merged. Reviewers mention easy intake and helpful clinicians, while others report delayed orders and customer-support problems. Feedback is not specific to clinical outcomes. Read the profile directly to see the full range of recent comments. Reviews reflect individual experiences and do not verify a prescription, medication quality or expected result.
How it compares
| Decision point | Embody | What to compare |
|---|---|---|
| Access | consumer telehealth intake and clinician-review program advertising compounded GLP-1 injections | Check whether direct enrollment or an employer benefit is required. |
| Price | Website advertises compounded semaglutide from $79/month and compounded tirzepatide from $129/month; the checkout price depends on 4-, 12-, 24- or 52-week plan selection. | Compare the actual full charge and treatment supply, not only the monthly equivalent. |
| Clinical pathway | See provider/process details above | Identify the treating clinician, pharmacy and follow-up route. |
| Customer feedback | 3.8/5; 7507 Trustpilot reviews | Check the profile size, recency, scope and unresolved complaints. |
For comparison, an employer-covered program such as Omada works differently from a direct-to-consumer medication plan. A branded OTC medicine such as alli is also not interchangeable with a telehealth prescription service. Match the care model to your needs and confirm options with a qualified clinician.
Frequently asked questions
How much does Embody cost?
The site advertises compounded semaglutide from $79/month and tirzepatide from $129/month. It says price depends on the 4-, 12-, 24- or 52-week plan selected at checkout.
Is medication included?
The advertised plans describe medication and shipping, but confirm the exact product, total charge and included follow-up in the checkout terms.
Does Embody use FDA-approved GLP-1s?
The featured injections are described as compounded; Embody states these are not evaluated or approved by FDA.
What do Trustpilot reviews say?
The merged company profile showed 3.8/5 from about 7,500 reviews, with both positive intake/provider comments and complaints about delivery and support.
Sources
We checked official service, pricing and policy pages and the linked public feedback profile where available on September 24, 2026. The company’s own claims are identified as claims; customer reviews are presented as individual feedback.
- Embody homepage and pricing
- Embody products and plan options
- FDA policy for GLP-1 compounding
- FDA concerns about unapproved GLP-1 drugs
- Trustpilot Embody profile
How we researched and scored
We reviewed the linked brand pages, current pricing and FAQ pages, terms where available, regulatory statements and the matching Trustpilot profile. We compared published facts rather than conducting a clinical trial or mystery-shopper purchase. Prices, benefit availability, state coverage and product offerings can change. The score is based on the published criteria shown above and should not be read as a medical recommendation.
Final verdict
Embody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipping. The website discloses that compounded medicines are not FDA-approved; confirm the plan term and full upfront charge before purchase. Trustpilot showed a 3.8 score and more than 7,500 reviews on a profile that has been merged with other profiles. Review summaries include positive comments on easy intake and provider interactions, as well as complaints about delayed or missing shipments and difficulty getting support. These are customer reports, not verified clinical or product-quality findings. Before enrolling or purchasing, verify the current full price, treatment and terms directly with the company and discuss medical questions with a licensed healthcare professional.
Alternatives
Ro Body pairs FDA-approved brand-name GLP-1s at manufacturer-matched prices with a separate membership. All-in cost is $298 to $598 a month month-to-month, or from…
$298/mo
8.1/10
Editor's choice
Trimi offers online provider review and bundled compounded GLP-1 plans. Its lowest advertised monthly rates require substantial prepaid commitments. Trustpilot currently displays a guidelines-breach…
September 24, 2026
7.9/10
Frequently asked questions
The site advertises compounded semaglutide from $79/month and tirzepatide from $129/month. It says price depends on the 4-, 12-, 24- or 52-week plan selected at checkout.
The advertised plans describe medication and shipping, but confirm the exact product, total charge and included follow-up in the checkout terms.
The featured injections are described as compounded; Embody states these are not evaluated or approved by FDA.
The merged company profile showed 3.8/5 from about 7,500 reviews, with both positive intake/provider comments and complaints about delivery and support.
Sources
- Embody homepage and pricing joinem.co · checked September 24, 2026
- Embody products and plan options joinem.co · checked September 24, 2026
- FDA policy for GLP-1 compounding www.fda.gov · checked September 24, 2026
- FDA concerns about unapproved GLP-1 drugs www.fda.gov · checked September 24, 2026
- Trustpilot Embody profile www.trustpilot.com · checked September 24, 2026
How we test
TirzaSema GLP-1 Provider Scoring Methodology
This methodology explains how TirzaSema scores GLP-1 telehealth providers and programs. Scores are a weighted average of five categories, and every review shows the full breakdown. Affiliate relationships and commission rates are not part of the methodology.
- Cost and price transparency (30%): total monthly cost at common doses, including membership, consultation and shipping fees, and how clearly this is shown before payment.
- Medication options and sourcing (20%): FDA-approved brand-name and/or compounded options, how clearly compounded products are labeled, and dispensing-pharmacy information.
- Medical care and safety (20%): eligibility assessment, licensed-clinician review, dose and side-effect monitoring, and follow-up care.
- Ease of use and access (15%): sign-up process, time to treatment, states served, and insurance support.
- Customer support and policies (15%): responsiveness, cancellation and refund terms, auto-renewal clarity, and patterns in public customer feedback.
We research prices using provider and manufacturer public pages. Where published, we separate medication, membership, consultation and shipping charges, note dose or term differences, and label introductory offers. Each review states when its sources were checked. We have not enrolled in or bought a service unless that specific review explicitly describes hands-on testing. Confirm current terms and eligibility with the provider.
FDA-approved medications are reference entries with their labeled uses and official manufacturer information; our provider ratings do not measure a treatment’s clinical effectiveness.
Some links on TirzaSema are affiliate links. Commissions never affect scores, rankings, pros and cons, or medical and regulatory information. See our Affiliate Disclosure.
Final verdict
Embody advertises clinician-guided weight care with compounded semaglutide and tirzepatide, with online intake and shipping. The website discloses that compounded medicines are not FDA-approved; confirm the plan term and full upfront charge before purchase. Trustpilot showed a 3.8 score and more than 7,500 reviews on a profile that has been merged with other profiles. Review summaries include positive comments on easy intake and provider interactions, as well as complaints about delayed or missing shipments and difficulty getting support. These are customer reports, not verified clinical or product-quality findings.
Embody compounded GLP-1 weight-care plans
T
Written by
TirzaSema Editorial Team
Research and editorial team
The TirzaSema Editorial Team researches U.S. GLP-1 prices and telehealth programs using official manufacturer, FDA and provider sources. Every review states whether it is based on hands-on testing or on research of public information,…
Related
Editor's choice
Shed offers online weight-loss, hair and wellness treatments, with compounded and FDA-approved medication options. See current starting prices, what FDA approval means, Trustpilot feedback,…
$199/mo
5.7/10
Men’s health clinic with compounded GLP-1s: semaglutide about $165/month, tirzepatide $315+. Sold in bundles, with limited refunds. Checked Oct 1, 2026.
$40/mo
5.8/10
Compounded semaglutide at $179 first month then $299, or $249/month on longer plans, with free shipping. Checked Oct 1, 2026.
$249/mo
6.3/10